Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Real world outcomes of zanubrutinib monotherapy for CLL/SLL focusing on treatment discontinuation and BTKi switching: A single center retrospective analysis

Kai Shen, Chenlu Yang, Jinrong Yang, He Li, Jie Wang, Jiazhuo Liu, Yun Tang, Chuan He, Bing Xiang, Ting Niu

Blood (2025) 146 (Supplement 1): 7433.

https://doi.org/10.1182/blood-2025-7433

Published: 2025

Journal Articles

High HDAC I/IIb selective inhibitor purinostat mesylate in relapsed and refractory peripheral T-cell lymphoma: A single-agent phase IIa study

Ting Niu, Lin LIU, Huijing Wu, Keshu Zhou, Wei Yang, Li Wang, Shu Cheng, Jie Wang, Jinrong Yang, Fei Li, Shiyong Zhou, Yanhong Tong, Ke Tan, Adrian Rui Liang, linyu yang, Lijuan Chen, Wei Li Zhao

Blood (2025) 146 (Supplement 1): 5415.

https://doi.org/10.1182/blood-2025-5415

Published: 2025

Journal Articles

Mecapegfilgrastim for prophylaxis of immunochemotherapy-induced neutropenia in patients with diffuse large B-cell lymphoma: A multicenter pilot trial

Jie Wang, He LI, Qiaochu Lin, CHUNRONG MA, Jin Wei, Jie Zhou, Ting Niu

Blood (2025) 146 (Supplement 1): 7210.

https://doi.org/10.1182/blood-2025-7210

Published: 2025

Journal Articles

Identifying biological differences between two clinical risk groups of cutaneous CD30+ T cell lymphoproliferative disorders

Leonardo P. A. Biral, Veronica S. Russell, Chee Leong Cheng, Andrew Evans, Sirpa Leppä, Sarah Ondrejka, Payal Sojitra, Catalina Amador, Jean Koff, Cassandra Love, Jennifer Shingleton, Clayton Parker, Emily F. Mason, Raju Pillai, Yuri Fedoriw, Sandeep Dave, Jie Wang

Blood (2025) 146 (Supplement 1): 1747.

https://doi.org/10.1182/blood-2025-1747

Published: 2025

Journal Articles

Tumor-associated macrophages (CD68+) as a potential prognostic biomarker for PD-1 inhibitor response in relapsed/refractory classical Hodgkin lymphoma

Shiji Wang, Jie Wang, Mingzhi Zhang, Xudong Zhang, Hui Yu

Blood (2025) 146 (Supplement 1): 7137.

https://doi.org/10.1182/blood-2025-7137

Published: 2025

Journal Articles

Efficacy and safety of CAR-T cell therapy versus bispecific antibodies in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: A single-arm meta-analysis

Jie Wang, Mengke Huang, Yukai Duan, Shiji Wang, Xudong Zhang, Mingzhi Zhang, Hui Yu

Blood (2025) 146 (Supplement 1): 3741.

https://doi.org/10.1182/blood-2025-3741

Published: 2025

Journal Articles

Dual anti-HLH and antitumor efficacy of golidocitinib in relapsed/refractory PTCL-associated hemophagocytic lymphohistiocytosis: A retrospective safety and activity analysis

He Li, Jinrong Yang, Yun Tang, Yongqian Jia, Yang Dai, Jie Huang, Bing Xiang, Jie Wang, Xu Sun, Ailin Zhao, Ting Niu

Blood (2025) 146 (Supplement 1): 6303.

https://doi.org/10.1182/blood-2025-6303

Published: 2025

Journal Articles

Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort

Blood (2025) 146 (Supplement 1): 1054.

https://doi.org/10.1182/blood-2025-1054

Published: 2025

Journal Articles

Efficacy and safety of orelabrutinib monotherapy in patients with chronic lymphocytic leukemia: A retrospective real-world study

Kai Shen, Chenlu Yang, Jinrong Yang, He Li, Jie Wang, Jiazhuo Liu, Yun Tang, Chuan He, Bing Xiang, Ting Niu

Blood (2025) 146 (Supplement 1): 7422.

https://doi.org/10.1182/blood-2025-7422

Published: 2025

Journal Articles

Disparities in CAR-T Therapy Access and Outcomes: Variation in Referral Patterns for CAR-T Therapy in Patients with Newly Diagnosed Malignancies at an Academic Center in North Carolina

Blood (2024) 144 (Supplement 1): 5044.

https://doi.org/10.1182/blood-2024-211637

Published: 2024

Journal Articles

Clinical Outcomes of EBV-Positive Compared to EBV-Negative Diffuse Large B Cell Lymphoma in the Modern Era

Kristen McClellan, Cheryl Chang, Anivarya Kumar, John Hsu, Samantha M Thomas, Jie Wang

Blood (2024) 144 (Supplement 1): 3088.

https://doi.org/10.1182/blood-2024-198231

Published: 2024

Journal Articles

Asparaginase Treatment Patterns, Toxicity, and Outcomes Among Patients with Extranodal NK/T-Cell Lymphoma: A North American Multicenter Retrospective Cohort Study

Blood (2024) 144 (Supplement 1): 1690.

https://doi.org/10.1182/blood-2024-211424

Published: 2024

Journal Articles

3D Live Imaging and Phenotyping of the Subcellular Cytotoxicity in CAR-T Cell Immunotherapy

Liting Chen, Zhaofei Wang, Jie Wang, Jin Jin, Jia Wei, Yicheng Zhang, Peng Fei

Blood (2024) 144 (Supplement 1): 4781.

https://doi.org/10.1182/blood-2024-193597

Published: 2024

Journal Articles

Survival and Therapeutic Outcomes in T-Cell Prolymphocytic Leukemia (T-PLL): A Collaborative Multi-Center Study Cohort

Blood (2024) 144 (Supplement 1): 982.

https://doi.org/10.1182/blood-2024-194242

Published: 2024

Journal Articles

Orelabrutinib-Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Treatment of Marginal Zone Lymphoma: A Retrospective Study

He LI, Jiazhuo Liu, Yuhui Chen, Pazilaiti Tuohuti, Yutong Wang, Xinzhu Tang, Bing Xiang, Yongqian Jia, Yu Wu, Yun Tang, Yong Guo, Jie Wang, Yuhuan Zheng, Yu Liu, Ting Niu

Blood (2024) 144 (Supplement 1): 6308.

https://doi.org/10.1182/blood-2024-206464

Published: 2024

Journal Articles

Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Lymphoma

Blood (2024) 144 (Supplement 1): 4406.

https://doi.org/10.1182/blood-2024-194601

Published: 2024

Journal Articles

First-in-Human Phase I/IIa Safety and Efficacy of Flonoltinib Maleate, a New Generation of JAK2/FLT3 Inhibitor in Myelofibrosis

Lijuan Chen, Yongsheng Wang, Jie Wang, Linyu Yang, Ting Niu

Blood (2024) 144 (Supplement 1): 486.

https://doi.org/10.1182/blood-2024-210674

Published: 2024

Journal Articles

Zanubrutinib Plus R-CHOP (ZR-CHOP) in Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients Who Were Positron Emission Tomography-Positive after Two Cycles of R-CHOP: A Single-Arm, Open-Label, Multicenter Prospective Study

Jie Wang, He Li, Chenlu Yang, Di Wu, Xingli Zou, Tao Yang, Liangliang Ma, Fang Xu, Jie Wang, Minggang Su, Sha Zhao, Lin Ji, Yao Liu, Pengcheng He, Ting Niu

Blood (2024) 144 (Supplement 1): 4488.

https://doi.org/10.1182/blood-2024-193927

Published: 2024

Journal Articles

Mecapegfilgrastim for Preventing Chemotherapy-Induced Neutropenia in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter, Open-Label, Randomized Controlled Trial

Jie Wang, He LI, Qiaochu Lin, Kun Yang, Chunrong Ma, Hong Zhai, Jin Wei, Yan Zuo, Jie Zhou, Ting Niu

Blood (2024) 144 (Supplement 1): 6498.

https://doi.org/10.1182/blood-2024-206431

Published: 2024

Journal Articles

Lymphoma Treatment Alterations in the Context of Autoimmune Disease

Shannon McGue, Andrea Sitlinger, Sophia Chang, Annie Wang, Samantha Thomas, Jie Wang

Blood (2023) 142 (Supplement 1): 4495.

https://doi.org/10.1182/blood-2023-188097

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Real world outcomes of zanubrutinib monotherapy for CLL/SLL focusing on treatment discontinuation and BTKi switching: A single center retrospective analysis

High HDAC I/IIb selective inhibitor purinostat mesylate in relapsed and refractory peripheral T-cell lymphoma: A single-agent phase IIa study

Mecapegfilgrastim for prophylaxis of immunochemotherapy-induced neutropenia in patients with diffuse large B-cell lymphoma: A multicenter pilot trial

Identifying biological differences between two clinical risk groups of cutaneous CD30+ T cell lymphoproliferative disorders

Tumor-associated macrophages (CD68+) as a potential prognostic biomarker for PD-1 inhibitor response in relapsed/refractory classical Hodgkin lymphoma

Efficacy and safety of CAR-T cell therapy versus bispecific antibodies in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: A single-arm meta-analysis

Dual anti-HLH and antitumor efficacy of golidocitinib in relapsed/refractory PTCL-associated hemophagocytic lymphohistiocytosis: A retrospective safety and activity analysis

Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort

Efficacy and safety of orelabrutinib monotherapy in patients with chronic lymphocytic leukemia: A retrospective real-world study

Disparities in CAR-T Therapy Access and Outcomes: Variation in Referral Patterns for CAR-T Therapy in Patients with Newly Diagnosed Malignancies at an Academic Center in North Carolina

Clinical Outcomes of EBV-Positive Compared to EBV-Negative Diffuse Large B Cell Lymphoma in the Modern Era

Asparaginase Treatment Patterns, Toxicity, and Outcomes Among Patients with Extranodal NK/T-Cell Lymphoma: A North American Multicenter Retrospective Cohort Study

3D Live Imaging and Phenotyping of the Subcellular Cytotoxicity in CAR-T Cell Immunotherapy

Survival and Therapeutic Outcomes in T-Cell Prolymphocytic Leukemia (T-PLL): A Collaborative Multi-Center Study Cohort

Orelabrutinib-Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Treatment of Marginal Zone Lymphoma: A Retrospective Study

Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Lymphoma

First-in-Human Phase I/IIa Safety and Efficacy of Flonoltinib Maleate, a New Generation of JAK2/FLT3 Inhibitor in Myelofibrosis

Zanubrutinib Plus R-CHOP (ZR-CHOP) in Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients Who Were Positron Emission Tomography-Positive after Two Cycles of R-CHOP: A Single-Arm, Open-Label, Multicenter Prospective Study

Mecapegfilgrastim for Preventing Chemotherapy-Induced Neutropenia in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter, Open-Label, Randomized Controlled Trial

Lymphoma Treatment Alterations in the Context of Autoimmune Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only